Sierra Capital LLC Merck & Co., Inc. Transaction History

Sierra Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$84.53 - $94.96 $15,468 - $17,377	-183 Reduced 5.63%	3,070 $264,000
Q2 2022 Aug 04, 2022	SELL	$83.49 - $94.64 $9,684 - $10,978	-116 Reduced 3.44%	3,253 $297,000
Q1 2022 May 03, 2022	BUY	$73.51 - $82.4 $6,468 - $7,251	88 Added 2.68%	3,369 $276,000
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $85,868 - $107,561	1,188 Added 56.76%	3,281 $251,000
Q3 2021 Nov 02, 2021	SELL	$71.68 - $78.83 $72,683 - $79,933	-1,014 Reduced 32.64%	2,093 $157,000
Q1 2021 May 28, 2021	BUY	$68.86 - $81.11 $213,948 - $252,008	3,107 New	3,107 $228,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $257B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Sierra Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Sierra Capital LLC with notifications on news.